Hydrocodone Extended-Release Tablets and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Hydrocodone Extended-Release Tablets and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydrocodone Extended-Release Tablets-Insulin degludec
- Hydrocodone Extended-Release Tablets-Insulin Degludec (U-100) Prefilled Pens
- Hydrocodone Extended-Release Tablets-Insulin Degludec (U-100) Vials
- Hydrocodone Extended-Release Tablets-Insulin Degludec (U-200) Prefilled Pens
- Hydrocodone Extended-Release Tablets-Insulin degludec and liraglutide
- Hydrocodone Extended-Release Tablets-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Insulin aspart, recombinant Subcutaneous-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Insulin aspart, recombinant Subcutaneous-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Insulin aspart, recombinant Subcutaneous-Hydrocortisone
- Insulin aspart, recombinant Subcutaneous-Hydrocortisone (Systemic)
- Insulin aspart, recombinant Subcutaneous-Hydrocortisone 2.5%